Sep 30, 2024 / 02:00PM GMT
Tim Dyer - Addex Therapeutics Ltd - Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Hello, everyone. I'd like to thank you all for standing by and attending our half-year 2024 financial results conference call. I'm here with Mikhail Kalinichev, Head of Translational Science who will be providing an update on our R&D programs. I draw your attention to the press release and the financial statements issued earlier today, which are available on our website.
Unfortunately, there has been a technical issue with loading the presentation to the webcast system, so please use the download button in order to download the presentation. We will be indicating slide numbers so that you will be able to follow hopefully.
So on to slide 3, the disclaimer slide. I also draw your attention to our disclaimers. We will be making certain forward-looking statements, that are based on the knowledge we have today.
I will start this conference call by giving a quick overview of our recent activities and achievements before reviewing our pipeline. I will then hand
Q2 2024 Addex Therapeutics Ltd Earnings Call Transcript
Sep 30, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers